2024 HCPCS Code G2215
Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
TAGS: separately primary nasal supply treatment addition spray procedure opioid
| Short Description | Home supply nasal naloxone |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2022 |
| HCPCS Code Added Date | January 01, 2021 |
| HCPCS Pricing Indicator Code | 11 - Price established using national rvu's |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- G9195 - Mdd pt not treated for 180d
- G9196 - Med reason for no ceph
- G9197 - Order for ceph
- G9198 - No order for ceph no reason
- G9199 - Doc reason for no vte
- G9200 - No reason for no vte
- G9201 - Vte given upon admission
- G9202 - Hep c aby pos
- G9203 - Hep c rna done prior to med
- G9204 - No reason for no hep c rna
- G9205 - Hep c antiviral started
- G9206 - Hep c therapy started
- G9207 - Hep c genotype prior to med
- G9208 - No reason for no hep c geno
- G9209 - Hep c rna 4to12 wk after med
- G9210 - No hepc rna after med docrsn
- G9211 - No hepc rna after med no rsn
- G9212 - Doc of dsm-iv init eval
- G9213 - No doc of dsm-iv
- G9214 - Cd4 count documented